Scholars@Duke
Journal cover image

Moving precision forward: extending next generation sequencing to operable disease in less common breast cancer subtypes.

Publication ,  Journal Article
Thomas, A; Shatsky, R; Kalinsky, K
Published in: Ann Oncol
January 2024
Published version (DOI) Link to item

Duke Scholars

Alexandra Thomas
Author Alexandra Thomas Medicine, Medical Oncology

Published In

Ann Oncol

DOI

10.1016/j.annonc.2023.10.127

EISSN

1569-8041

Publication Date

January 2024

Volume

35

Issue

1

Start / End Page

7 / 9

Location

England

Related Subject Headings

  • Receptor, erbB-2
  • Receptor, ErbB-2
  • Oncology & Carcinogenesis
  • Mutation
  • Humans
  • High-Throughput Nucleotide Sequencing
  • Female
  • Breast Neoplasms
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Thomas, A., Shatsky, R., & Kalinsky, K. (2024). Moving precision forward: extending next generation sequencing to operable disease in less common breast cancer subtypes. Ann Oncol, 35(1), 7–9. https://doi.org/10.1016/j.annonc.2023.10.127
Thomas, A., R. Shatsky, and K. Kalinsky. “Moving precision forward: extending next generation sequencing to operable disease in less common breast cancer subtypes.” Ann Oncol 35, no. 1 (January 2024): 7–9. https://doi.org/10.1016/j.annonc.2023.10.127.
Thomas, A., et al. “Moving precision forward: extending next generation sequencing to operable disease in less common breast cancer subtypes.” Ann Oncol, vol. 35, no. 1, Jan. 2024, pp. 7–9. Pubmed, doi:10.1016/j.annonc.2023.10.127.
Journal cover image

Published In

Ann Oncol

DOI

10.1016/j.annonc.2023.10.127

EISSN

1569-8041

Publication Date

January 2024

Volume

35

Issue

1

Start / End Page

7 / 9

Location

England

Related Subject Headings

  • Receptor, erbB-2
  • Receptor, ErbB-2
  • Oncology & Carcinogenesis
  • Mutation
  • Humans
  • High-Throughput Nucleotide Sequencing
  • Female
  • Breast Neoplasms
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences